We believe that the new vaccine can bring protection against rotavirus to the children who need it most.
This new We believe that the new vaccine can bring protection against rotavirus to the children who need it most. vaccine is heat stable and was found to be 66.7% effective at preventing severe gastroenteritis – a symptom of the virus.
A new vaccine that could possibly prevent a deadly diarrheal disease that causes high mortality among children has proven to be safe and effective, a new trial conducted in Africa states.
The disease, called rotavirus, has killed hundreds of children.
The two existing rotavirus vaccines are expensive to manufacture and need to be refrigerated, making them difficult to bring to countries with little resources where electricity is inaccessible.
An innovative rotavirus vaccine, BRV-PV, which does not require refrigeration, has passed Phase III trials in children living in sub-n Africa
BRV-PV will not only allow for easier access to a rotavirus vaccine in remote areas, but with an estimated cost of €2.30 ($2.50) a dose, the new vaccine is also cheaper than the two existing ones.
The success of this vaccine reveals the importance of vaccine development, which is specifically adapted for use in low-income countries.
The Research and Epidemiology branch of the humanitarian organization Doctors without Borders (MSF), Epicentre, has published the results of its recent Phase III trial for a new oral vaccine against rotavirus infection.
Rotavirus infection is the number one cause of severe diarrhea and kills an estimated 1,300 children each day primarily in sub-Saharan Africa.
referring to A vaccine that could prevent hundreds of thousands child deaths around the world by heading off a disease that causes severe diarrhea has been proven “safe and effective.”
Latest Quick Take: Is there a low-cost, heat-stable alternative for oral rotavirus vaccine?
“We believe that the new vaccine can bring protection against rotavirus to the children who need it most.”
Known as BRV-PV, the vaccine would protect children, from contracting the wickedly common rotavirus — and it just completed a successful trial in Niger.
Without a vaccine, almost all kids worldwide will be infected with #rotavirus between ages 3 to 5.
This content may collect you by Victoria Hunter